Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gemma Medcalf

- PMLiVE

Interview: Greg Perry, European Generic medicines Association

The director general of the European Generic medicines Association talks to Liz Wells about the challenges facing generic drug manufacturers and discusses how his organisation is working to boost the...

- PMLiVE

Interview: Jorge Gallardo, Almirall

The executive chairman of Spanish pharmaceutical company Almirall explains to PME editor Linda Banks how bold investment in R&D and international expansion are key to the company's growth

New self-care website for NHS

A new self-care website has been launched to provide NHS staff and patient groups with advice, information and practical tools to help encourage people to take care of themselves.

Halaven approved in Japan but not UK

Eisai's breast cancer treatment Halaven has been approved for use in Japan, while England's National Institute for Health and Clinical Excellence has issued draft guidance recommending against use of the...

UK DH commits to value-based pricing

England’s Department of Health has said it will continue to develop a new value-based pricing system for the purchase of drugs to be used in the NHS

Mobile app for conference highlights

Doctors.net.uk has launched a mobile phone app providing members with details of the latest medical conferences via their smartphone

- PMLiVE

The formation of the NHS

Exploring the industry's most important dates, we recall July 1948: the formation of the NHS in the UK

- PMLiVE

PMGroup launches New Health Strategies

PMGroup has announced the launch of New Health Strategies – a series of digital publications analysing key issues in healthcare policy, commencing with 'commissioning groups' within the NHS in England

UK diabetes risk levels rise

Over 800,000 people with diabetes in the UK are at risk of complications related to the condition due to high blood sugar levels according the National Diabetes Audit 2009-10

- PMLiVE

Interview: Richard Bergström, EFPIA

The new director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA) tells Liz Wells about the challenges involved in keeping the regional market sustainable 

NICE recommends RA drug

The UK's National Institute for Health and Clinical Excellence has issued final guidance recommending Centocor Ortho Biotech's rheumatoid arthritis drug Simponi in specific, limited circumstances

NICE to retain powers

As part of changes announced to the UK government's Health and Social Care Bill, the National Institute of Health and Clinical Excellence is to retain its responsibility to recommend drugs...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links